Marketing-authorisation holder ยท Canada
Janssen Inc
262 medicines in 1 country, as authorisation holder.
Loading your pageโฆ
Loading your pageโฆ
Marketing-authorisation holder ยท Canada
262 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1โ25 of 262
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AKEEGA500 mg + 50 mg ยท Tablet | Abiraterone, Niraparib | Canada | Marketed | 2023 |
| AKEEGA500 mg + 100 mg ยท Tablet | Abiraterone, Niraparib | Canada | Marketed | 2023 |
| BALVERSA4 mg ยท Tablet | Erdafitinib | Canada | Authorised | |
| BALVERSA4 mg ยท Tablet | Erdafitinib | Canada | Marketed | 2019 |
| BALVERSA3 mg ยท Tablet | Erdafitinib | Canada | Marketed | 2019 |
| BALVERSA5 mg ยท Tablet | Erdafitinib | Canada | Marketed | 2019 |
| CARIPUL1.5 mg / vial ยท Powder For Solution | Epoprostenol | Canada | Marketed | 2013 |
| CARIPUL0.5 mg / vial ยท Powder For Solution | Epoprostenol | Canada | Marketed | 2013 |
| CARVYKTI100000000 cells / bag ยท Suspension | Ciltacabtagene autoleucel | Canada | Authorised | |
| CONCERTA54 mg ยท Tablet (Extended-Release) | Methylphenidate | Canada | Marketed | 2003 |
| CONCERTA36 mg ยท Tablet (Extended-Release) | Methylphenidate | Canada | Marketed | 2003 |
| CONCERTA27 mg ยท Tablet (Extended-Release) | Methylphenidate | Canada | Marketed | 2005 |
| CONCERTA18 mg ยท Tablet (Extended-Release) | Methylphenidate | Canada | Marketed | 2003 |
| DARZALEX100 mg / 5 ml ยท Solution | Daratumumab | Canada | Marketed | 2016 |
| DARZALEX400 mg / 20 ml ยท Solution | Daratumumab | Canada | Marketed | 2016 |
| DARZALEX SC1800 mg / 15 ml ยท Solution | Daratumumab | Canada | Marketed | 2020 |
| EDURANT25 mg ยท Tablet | Rilpivirine | Canada | Marketed | 2011 |
| ELMIRON100 mg ยท Capsule | Pentosan polysulfate sodium | Canada | Marketed | 1993 |
| EPREX STERILE SOLUTION20000 unit / 0.5 ml ยท Solution | Epoetin alfa | Canada | Marketed | 2005 |
| EPREX STERILE SOLUTION30000 unit / 0.75 ml ยท Solution | Epoetin alfa | Canada | Marketed | 2007 |
| EPREX STERILE SOLUTION 10000IU/1.0ML10000 unit / ml ยท Solution | Epoetin alfa | Canada | Marketed | 1997 |
| EPREX STERILE SOLUTION 1000IU/0.5ML1000 unit / 0.5 ml ยท Solution | Epoetin alfa | Canada | Marketed | 1997 |
| EPREX STERILE SOLUTION 2000IU/0.5ML2000 unit / 0.5 ml ยท Solution | Epoetin alfa | Canada | Marketed | 1997 |
| EPREX STERILE SOLUTION 3000IU/0.3ML3000 unit / 0.3 ml ยท Solution | Epoetin alfa | Canada | Marketed | 1997 |
| EPREX STERILE SOLUTION 40000IU/ML40000 unit / ml ยท Solution | Epoetin alfa | Canada | Marketed | 1999 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 262 | 121 | 141 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.